Latest at Cipla
Why technological advancement is the key to unlocking a robust healthcare system in India
Technology will play an indispensable role in shaping the healthcare systems of the future. In the past two years, it has certainly helped the stakeholders adapt to disruptions almost overnight and become more efficient
Cipla Health Set to Acquire Nutritional Supplement Brand Endura Mass
Endura and all other associated trademarks would be part of the acquisition. CHL will initiate the distribution and marketing of the Endura Mass pending the closure of the proposed acquisition.
Cipla buys additional stake in digital health company GoApptiv
Post completion of the deal, Cipla’s total stake in GoApptiv will increase to 22.02% on a fully diluted basis. The investment will be made in equity shares and compulsorily convertible preference shares and is likely to be completed within 30 days or such other date mutually agreed between the parties subject to fulfillment of necessary closing conditions, Cipla said in a statement.
Pills to wellness, Cipla is seeking a new identity
One of the major successes of Hamied was building a strong US business, despite Cipla being a late entrant. Hamied said this was made possible by pursuing selective yet complex generic portfolios. Cipla entered US in a big way with the strategic acquisitions of two generic companies, InvaGen Pharma and Exelan Pharma, for $550 mn in 2015.
ET Businesswoman of the Year 2021: Samina Hamied
ET Businesswoman of the Year 2021: Samina Hamied - The woman who carries forward a storied legacy, seeking profit, but never at the cost of values.
“I am humbled and honoured to receive the ET’s Businesswoman of the Year Award. This recognition belongs to each and every one of our 25,000 employees who stand with Cipla, putting patients’ interests before their own and upholding our purpose of Caring for Life,” Hamied, executive vice-chairperson, Cipla, told ET.
BS Awards for Corporate Excellence 2021: Samina Hamied lauds team effort
Cipla, which has seen a generational change in its leadership, draws 40 per cent of its revenues from India and 21 per cent from the US market.
The Medicine Box: Cipla looks to increase presence in US market
Cipla the third largest pharma company in India, present in more than 80 countries with over 47 manufacturing facilities is now focusing more towards difficult to manufacture complex drugs and injectables in segments such as respiratory and cancer. The company is also looking to grow its presence in the US. To discuss the growth outlook, CNBC-TV18 spoke to Umang Vohra, MD & Global CEO of Cipla.
Leapfrogging into the future of Indian pharma
The article has been authored by Samina Hamied, executive vice-chairperson, Cipla and vice-president, Indian Pharmaceutical Alliance.
The Indian pharmaceutical industry ranks third worldwide for production by volume and caters to 20% of the global demand in the generic market in terms of volume.(AP)
Therapies at Cipla
With our growing scientific understanding of rare diseases, we shall continue to introduce ground breaking therapies to give our patients their new beginnings!
Life at Cipla
Stock Price Index
Hear it from the Cipla-ites!
I was impressed by Cipla´s quest of making it possible for everyone to have access to the most advanced medicines manufactured in world-class factories. As we could see in our virtual visit, The Cipla Palliative Care Project is an initiative that defines Cipla’s focus on human values and devotion towards humankind’s welfare. I totally identify with Cipla´s business model, and I am proud to be part of a company that takes responsibility of the society’s well-being and leads by an example.
My journey with Cipla began in October 2019 and after joining I realized that the work environment and culture here is excellent. A huge pharmaceutical company, with a diversified work force and good policies makes Cipla a perfect employer of choice for me. During this pandemic, I really appreciate Cipla’s team for taking care of all employees and their families by providing medicines, arranging hospital beds and hotel for quarantine. In case of any untimely death, the kind of financial, medical and educational support is provided to employee’s family is really unbelievable.
I feel immense pride to be a part of this leading multinational pharmaceutical company that’s always been at the forefront of science and technology while tirelessly serving the society. Here, the leaders lead by example: inspiring, guiding and mentoring us along the way. Our culture and CSR activities are a true example of how a successful business can also be a face of humanity. My personal encounter with a stranger thanking and blessing me profusely for the noble work carried out at Cipla Palliative Care division, made me realise how great yet humble my organisation is.
Cipla holds a special place in my life – both professionally and personally. It's an organization where you can plan your long innings of growth, the atmosphere here is very warm and positive. There is a true sense of respect, belonging and involvement at each level. Cipla does not believe in boundaries and there is always encouragement to learn and evolve. In the times of Covid, Cipla stood like a rock for its employees and took them under its wings, be it in terms of medicine availability, treatment availability or financial support.
With Cipla Foundation, we envision and execute Cipla’s Corporate Social Responsibility. In the last year, we have reached out to over 2,20,000 individuals in the community across in Health, Education, Skilling and Disaster Response.
Support replicable and scalable models towards sustainable change.
Generate evidence, knowledge and skilled workforce in our chosen domains.
Support to communities affected by disasters.
Sparking the curiosity for learning.